Skip to content

Meritage Homes MTH Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$55.31M-34.2%$84.03M-15.4%$99.3M-32.4%$146.88M+19.6%$122.81M-28.9%
$5.37M-19.6%$6.68M+11.5%$5.99M-10.1%$6.66M+12.0%$5.95M-9.9%
$5.86M+19.5%$4.9M+0.9%$4.86M+35.1%$3.6M-43.1%$6.33M-2.8%
-$34.05M$188.61M+15.1%$163.8M+169%$60.82M-76.2%
-$43.27M+8.0%-$47.04M-93.5%-$24.31M-389%-$4.97M+69.0%-$16.04M+74.7%
$2.07M$11.03M+50.2%$7.34M+1,401%$489K
$1.69M+918%-$207K+86.5%-$1.53M+77.2%-$6.7M-134%-$2.86M+75.4%
$656K-21.9%$840K-13.3%$969K-37.0%$1.54M+146%$626K-88.2%
-$29.02M$34.58M+514%$5.63M-85.0%$37.64M+216%
$673K+63.7%$411K-74.6%$1.62M+5.8%$1.53M+160%$588K-83.0%
$101.31M-58.4%$243.67M+352%-$96.51M-804%$13.7M+132%-$42.58M+57.2%
$4.31M-22.8%$5.58M-28.4%$7.79M+15.1%$6.77M+21.0%$5.59M-25.3%
$94K+40.3%$67K+15.5%$58K-40.2%$97K+234%$29K-65.1%
$3.52M-69.8%$11.65M-0.5%$11.7M+232%$3.53M-39.7%$5.85M-27.8%
-$7.73M+53.6%-$16.66M+14.3%-$19.43M-90.6%-$10.2M+10.7%-$11.41M+9.7%
$32.02M+9.2%$29.31M-3.2%$30.28M-1.1%$30.6M-0.9%$30.89M+14.5%
$130M-13.3%$150M+173%$55M+22.2%$45M0.0%$45M+12.5%
$0$497.2M
$0$33K-99.3%$5.07M
-$102.1M$414.09M
-$8.53M-118%$46.22M$360.1M+300%
$673K+63.7%$411K-74.6%$1.62M+5.8%$1.53M+160%$588K-83.0%
$2.43M-72.5%$8.83M-5.0%$9.29M$0$0
$656K-21.9%$840K-13.3%$969K-37.0%$1.54M+146%$626K-88.2%
-$29.02M$34.58M+514%$5.63M-85.0%$37.64M+216%
-$7.39M$62.18M
$3.52M-69.8%$11.65M-0.5%$11.7M+232%$3.53M-39.7%$5.85M-27.8%
$94K+40.3%$67K+15.5%$58K-40.2%$97K+234%$29K-65.1%
$0$33K-99.3%$5.07M
$0$497.2M
$33K-97.8%$1.48M+380%$309K-96.6%$9.06M+322%$2.15M+98.5%
$97M-59.3%$238.1M+328%-$104.3M-1,604%$6.93M+114%-$48.17M+55.0%
$97M-59.3%$238.1M+328%-$104.3M-1,604%$6.93M+114%-$48.17M+55.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Meritage Homes's cash flow data come from?
Every line is extracted from Meritage Homes's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.